215 related articles for article (PubMed ID: 8035478)
1. Human immunodeficiency virus type 1 integrase: effect on viral replication of mutations at highly conserved residues.
Cannon PM; Wilson W; Byles E; Kingsman SM; Kingsman AJ
J Virol; 1994 Aug; 68(8):4768-75. PubMed ID: 8035478
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain.
Masuda T; Planelles V; Krogstad P; Chen IS
J Virol; 1995 Nov; 69(11):6687-96. PubMed ID: 7474078
[TBL] [Abstract][Full Text] [Related]
3. Integrase mutants of human immunodeficiency virus type 1 with a specific defect in integration.
Taddeo B; Haseltine WA; Farnet CM
J Virol; 1994 Dec; 68(12):8401-5. PubMed ID: 7966634
[TBL] [Abstract][Full Text] [Related]
4. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication.
Engelman A; Englund G; Orenstein JM; Martin MA; Craigie R
J Virol; 1995 May; 69(5):2729-36. PubMed ID: 7535863
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection.
Leavitt AD; Robles G; Alesandro N; Varmus HE
J Virol; 1996 Feb; 70(2):721-8. PubMed ID: 8551608
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells.
Wiskerchen M; Muesing MA
J Virol; 1995 Jan; 69(1):376-86. PubMed ID: 7983732
[TBL] [Abstract][Full Text] [Related]
7. Conserved sequences in the carboxyl terminus of integrase that are essential for human immunodeficiency virus type 1 replication.
Cannon PM; Byles ED; Kingsman SM; Kingsman AJ
J Virol; 1996 Jan; 70(1):651-7. PubMed ID: 8523588
[TBL] [Abstract][Full Text] [Related]
8. Characterization of human immunodeficiency virus type 1 integrase expressed in Escherichia coli and analysis of variants with amino-terminal mutations.
Vincent KA; Ellison V; Chow SA; Brown PO
J Virol; 1993 Jan; 67(1):425-37. PubMed ID: 8416376
[TBL] [Abstract][Full Text] [Related]
9. Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells.
LaFemina RL; Schneider CL; Robbins HL; Callahan PL; LeGrow K; Roth E; Schleif WA; Emini EA
J Virol; 1992 Dec; 66(12):7414-9. PubMed ID: 1433523
[TBL] [Abstract][Full Text] [Related]
10. Genetic analysis of the human immunodeficiency virus type 1 integrase protein.
Shin CG; Taddeo B; Haseltine WA; Farnet CM
J Virol; 1994 Mar; 68(3):1633-42. PubMed ID: 8107224
[TBL] [Abstract][Full Text] [Related]
11. Conserved residues Pro-109 and Asp-116 are required for interaction of the human immunodeficiency virus type 1 integrase protein with its viral DNA substrate.
Drelich M; Haenggi M; Mous J
J Virol; 1993 Aug; 67(8):5041-4. PubMed ID: 8392628
[TBL] [Abstract][Full Text] [Related]
12. Sequences in the human immunodeficiency virus type 1 U3 region required for in vivo and in vitro integration.
Reicin AS; Kalpana G; Paik S; Marmon S; Goff S
J Virol; 1995 Sep; 69(9):5904-7. PubMed ID: 7637038
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the human spuma retrovirus integrase by site-directed mutagenesis, by complementation analysis, and by swapping the zinc finger domain of HIV-1.
Pahl A; Flügel RM
J Biol Chem; 1995 Feb; 270(7):2957-66. PubMed ID: 7852375
[TBL] [Abstract][Full Text] [Related]
14. Site-directed mutagenesis of HIV-1 integrase demonstrates differential effects on integrase functions in vitro.
Leavitt AD; Shiue L; Varmus HE
J Biol Chem; 1993 Jan; 268(3):2113-9. PubMed ID: 8420982
[TBL] [Abstract][Full Text] [Related]
15. Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1.
Englund G; Theodore TS; Freed EO; Engelman A; Martin MA
J Virol; 1995 May; 69(5):3216-9. PubMed ID: 7707554
[TBL] [Abstract][Full Text] [Related]
16. Analysis of human immunodeficiency virus type 1 integrase mutants.
Ansari-Lari MA; Donehower LA; Gibbs RA
Virology; 1995 Aug; 211(1):332-5. PubMed ID: 7544046
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31.
Lee-Huang S; Huang PL; Huang PL; Bourinbaiar AS; Chen HC; Kung HF
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8818-22. PubMed ID: 7568024
[TBL] [Abstract][Full Text] [Related]
18. Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro.
Engelman A; Craigie R
J Virol; 1992 Nov; 66(11):6361-9. PubMed ID: 1404595
[TBL] [Abstract][Full Text] [Related]
19. A basis for new approaches to the chemotherapy of AIDS: novel genes in HIV-1 potentially encode selenoproteins expressed by ribosomal frameshifting and termination suppression.
Taylor EW; Ramanathan CS; Jalluri RK; Nadimpalli RG
J Med Chem; 1994 Aug; 37(17):2637-54. PubMed ID: 8064794
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the human immunodeficiency virus type 1 integrase D,D(35)E motif do not eliminate provirus formation.
Gaur M; Leavitt AD
J Virol; 1998 Jun; 72(6):4678-85. PubMed ID: 9573231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
